MHC Class I Chain-Related Gene A (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Cell Transplantations Has No Impact on Outcomes in Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome: A Center for International Blood and Marrow Transplant Research Study
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Mar 01, 2017
- Source ID
- 10.1016/j.bbmt.2016.11.021
Entities
People
- Abeer Madbouly
- Aiwen Zhang
- Dawn Thomas
- Katharina Fleischhauer
- Katharine C Hsu
- Marcelo Fernandez-viña
- Medhat Askar
- Michael R Verneris
- Mike Haagenson
- Navneet S Majhail
- Ronald Sobecks
- Stephanie J. Lee
- Stephen R. Spellman
- Tao Wang
Organizations
- Alexion Pharmaceuticals
- American Cancer Society
- Amgen
- Astellas Pharma (United States)
- AstraZeneca
- AstraZeneca (United States)
- Bristol-Myers Squibb
- Celgene
- Chiron Corporation
- Cleveland Clinic
- Elevance Health, Inc.
- Fred Hutchinson Cancer Center
- Genzyme
- Gilead Sciences
- Health Resources and Services Administration
- Incyte
- Janssen Scientific Affairs (United States)
- Jazz Pharmaceuticals
- Medical College of Wisconsin
- Merck & Co.
- National Cancer Institute
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases
- National Marrow Donor Program
- Office of Naval Research
- Onyx Pharmaceuticals
- Otsuka (United States)
- Patient-Centered Outcomes Research Institute
- Pfizer
- Roche (United States)
- Sanofi-Aventis
- Seagen
- St. Baldrick's Foundation
- Swedish Orphan Biovitrum
- University of Minnesota